LAMEA Pain Management Devices Market By Product (Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices) By Application (Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications) By Country, Industry Analysis and Forecast, 2020 - 2026
The Latin America, Middle East and Africa Pain Management Devices Market would witness market growth of 9.6% CAGR during the forecast period (2020-2026).
Pain management device is used to treat chronic and acute pain in patients with different conditions, such as cancer, neurological disorders, and musculoskeletal disorders. These devices restore patients' ability to do daily activities, reduce the need for oral pain medicines, and improve the quality of life of patients suffering from these conditions.
Growing cancer cases have also resulted in increased demand for these devices to relieve pain caused by a tumor compressing one nerve and many other factors depending on the stage of cancer. The therapies are given to the patients often lead potentially to cancer pain. Studies have shown that about 20 to 50 percent of patients with cancer feel acute pain at the time of diagnosis and about 75 percent complain of pain during the development of the disease.
The major applications in the pain control equipment industry are cancer, neuropathic pain, facial pain and migraine, musculoskeletal diseases, and trauma. Neurostimulation devices play a significant role in managing neuropathic pain, as stimulators for the spinal cord deliver the best results. In addition, these devices provide benefits such as personalized stimulation rates, based on the activities that the individual undertakes in a day.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
Pain management device is used to treat chronic and acute pain in patients with different conditions, such as cancer, neurological disorders, and musculoskeletal disorders. These devices restore patients' ability to do daily activities, reduce the need for oral pain medicines, and improve the quality of life of patients suffering from these conditions.
Growing cancer cases have also resulted in increased demand for these devices to relieve pain caused by a tumor compressing one nerve and many other factors depending on the stage of cancer. The therapies are given to the patients often lead potentially to cancer pain. Studies have shown that about 20 to 50 percent of patients with cancer feel acute pain at the time of diagnosis and about 75 percent complain of pain during the development of the disease.
The major applications in the pain control equipment industry are cancer, neuropathic pain, facial pain and migraine, musculoskeletal diseases, and trauma. Neurostimulation devices play a significant role in managing neuropathic pain, as stimulators for the spinal cord deliver the best results. In addition, these devices provide benefits such as personalized stimulation rates, based on the activities that the individual undertakes in a day.
Based on Product, the market is segmented into Neuromodulation & Neurostimulation Devices, Analgesic Infusion Pumps and Ablation Devices. Based on Application, the market is segmented into Neuropathic Pain, Musculoskeletal Pain, Cancer Pain, Facial & Migraine Pain and Other Applications. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, B. Braun Melsungen AG, Baxter International, Inc., Pfizer, Inc., Boston Scientific Corporation, Johnson and Johnson, Medtronic PLC, Kimberly-Clark Corporation, Stryker Corporation, and Colfax Corporation (DJO Global, Inc.)
Scope of the Study
Market Segmentation:
By Product
- Neuromodulation & Neurostimulation Devices
- Analgesic Infusion Pumps and
- Ablation Devices
- Neuropathic Pain
- Musculoskeletal Pain
- Cancer Pain
- Facial & Migraine Pain and
- Other Applications
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
- Abbott Laboratories
- B. Braun Melsungen AG
- Baxter International, Inc.
- Pfizer, Inc.
- Boston Scientific Corporation
- Johnson and Johnson
- Medtronic PLC
- Kimberly-Clark Corporation
- Stryker Corporation
- Colfax Corporation (DJO Global, Inc.)
- Exhaustive coverage
- Highest number of market tables and figures
- Subscription based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
CHAPTER 1. MARKET SCOPE & METHODOLOGY
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Pain Management Devices Market, by Product
1.4.2 LAMEA Pain Management Devices Market, by Application
1.4.3 LAMEA Pain Management Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT
4.1 LAMEA Neuromodulation & Neurostimulation Devices Market by Country
4.2 LAMEA Analgesic Infusion Pumps Market by Country
4.3 LAMEA Ablation Devices Market by Country
CHAPTER 5. LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION
5.1 LAMEA Neuropathic Pain Market by Country
5.2 LAMEA Musculoskeletal Pain Market by Country
5.3 LAMEA Cancer Pain Market by Country
5.4 LAMEA Facial & Migraine Pain Market by Country
5.5 LAMEA Other Applications Market by Country
CHAPTER 6. LAMEA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY
6.1 Brazil Pain Management Devices Market
6.1.1 Brazil Pain Management Devices Market by Product
6.1.2 Brazil Pain Management Devices Market by Application
6.2 Argentina Pain Management Devices Market
6.2.1 Argentina Pain Management Devices Market by Product
6.2.2 Argentina Pain Management Devices Market by Application
6.3 UAE Pain Management Devices Market
6.3.1 UAE Pain Management Devices Market by Product
6.3.2 UAE Pain Management Devices Market by Application
6.4 Saudi Arabia Pain Management Devices Market
6.4.1 Saudi Arabia Pain Management Devices Market by Product
6.4.2 Saudi Arabia Pain Management Devices Market by Application
6.5 South Africa Pain Management Devices Market
6.5.1 South Africa Pain Management Devices Market by Product
6.5.2 South Africa Pain Management Devices Market by Application
6.6 Nigeria Pain Management Devices Market
6.6.1 Nigeria Pain Management Devices Market by Product
6.6.2 Nigeria Pain Management Devices Market by Application
6.7 Rest of LAMEA Pain Management Devices Market
6.7.1 Rest of LAMEA Pain Management Devices Market by Product
6.7.2 Rest of LAMEA Pain Management Devices Market by Application
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Baxter International, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 Johnson and Johnson
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Approvals:
7.7.5.3 Acquisition and Mergers:
7.7.5.4 Product Launches and Product Expansions:
7.8 Kimberly-Clark Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Stryker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 Colfax Corporation (DJO Global, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Pain Management Devices Market, by Product
1.4.2 LAMEA Pain Management Devices Market, by Application
1.4.3 LAMEA Pain Management Devices Market, by Country
1.5 Methodology for the research
CHAPTER 2. MARKET OVERVIEW
2.1 Introduction
2.1.1 Overview
2.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
CHAPTER 3. COMPETITION ANALYSIS - GLOBAL
3.1 KBV Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Mergers & Acquisitions
3.2.4 Approvals
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2016-2020)
3.3.2 Key Strategic Move: (Partnerships, Collaborations, and Agreements: 2016, Oct – 2020, May) Leading Players
CHAPTER 4. LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT
4.1 LAMEA Neuromodulation & Neurostimulation Devices Market by Country
4.2 LAMEA Analgesic Infusion Pumps Market by Country
4.3 LAMEA Ablation Devices Market by Country
CHAPTER 5. LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION
5.1 LAMEA Neuropathic Pain Market by Country
5.2 LAMEA Musculoskeletal Pain Market by Country
5.3 LAMEA Cancer Pain Market by Country
5.4 LAMEA Facial & Migraine Pain Market by Country
5.5 LAMEA Other Applications Market by Country
CHAPTER 6. LAMEA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY
6.1 Brazil Pain Management Devices Market
6.1.1 Brazil Pain Management Devices Market by Product
6.1.2 Brazil Pain Management Devices Market by Application
6.2 Argentina Pain Management Devices Market
6.2.1 Argentina Pain Management Devices Market by Product
6.2.2 Argentina Pain Management Devices Market by Application
6.3 UAE Pain Management Devices Market
6.3.1 UAE Pain Management Devices Market by Product
6.3.2 UAE Pain Management Devices Market by Application
6.4 Saudi Arabia Pain Management Devices Market
6.4.1 Saudi Arabia Pain Management Devices Market by Product
6.4.2 Saudi Arabia Pain Management Devices Market by Application
6.5 South Africa Pain Management Devices Market
6.5.1 South Africa Pain Management Devices Market by Product
6.5.2 South Africa Pain Management Devices Market by Application
6.6 Nigeria Pain Management Devices Market
6.6.1 Nigeria Pain Management Devices Market by Product
6.6.2 Nigeria Pain Management Devices Market by Application
6.7 Rest of LAMEA Pain Management Devices Market
6.7.1 Rest of LAMEA Pain Management Devices Market by Product
6.7.2 Rest of LAMEA Pain Management Devices Market by Application
CHAPTER 7. COMPANY PROFILES
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 Recent strategies and developments:
7.1.5.1 Partnerships, Collaborations, and Agreements:
7.1.5.2 Approvals:
7.2 B. Braun Melsungen AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental Analysis
7.2.4 Research & Development Expense
7.3 Baxter International, Inc.
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Regional Analysis
7.3.4 Research & Development Expense
7.3.5 Recent strategies and developments:
7.3.5.1 Approvals:
7.4 Pfizer, Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expense
7.5 Boston Scientific Corporation
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Segmental and Regional Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Acquisition and Mergers:
7.5.5.2 Product Launches and Product Expansions:
7.6 Johnson and Johnson
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Segmental &Regional Analysis
7.6.4 Research & Development Expenses
7.6.5 Recent strategies and developments:
7.6.5.1 Acquisition and Mergers:
7.7 Medtronic PLC
7.7.1 Company overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expenses
7.7.5 Recent strategies and developments:
7.7.5.1 Partnerships, Collaborations, and Agreements:
7.7.5.2 Approvals:
7.7.5.3 Acquisition and Mergers:
7.7.5.4 Product Launches and Product Expansions:
7.8 Kimberly-Clark Corporation
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Segmental and Regional Analysis
7.8.4 Research & Development Expense
7.9 Stryker Corporation
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Segmental and Regional Analysis
7.9.4 Research & Development Expense
7.9.5 Recent strategies and developments:
7.9.5.1 Acquisition and Mergers:
7.1 Colfax Corporation (DJO Global, Inc.)
7.10.1 Company Overview
7.10.2 Financial Analysis
7.10.3 Segmental and Regional Analysis
7.10.4 Research & Development Expense
7.10.5 Recent strategies and developments:
7.10.5.1 Product Launches and Product Expansions:
LIST OF TABLES
TABLE 1 LAMEA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– PAIN MANAGEMENT DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– PAIN MANAGEMENT DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – PAIN MANAGEMENT DEVICES MARKET
TABLE 6 APPROVALS – PAIN MANAGEMENT DEVICES MARKET
TABLE 7 LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 8 LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 9 LAMEA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 LAMEA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 LAMEA ABLATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA ABLATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 LAMEA NEUROPATHIC PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA NEUROPATHIC PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 LAMEA CANCER PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 LAMEA CANCER PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 LAMEA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 LAMEA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 LAMEA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 LAMEA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 BRAZIL PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 30 BRAZIL PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 31 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 32 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 33 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 34 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 35 ARGENTINA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 ARGENTINA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 38 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 39 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 40 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 41 UAE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 UAE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 UAE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 44 UAE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 45 UAE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 46 UAE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 47 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 50 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 51 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 52 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 53 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 56 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 57 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 58 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 59 NIGERIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 NIGERIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 62 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 63 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 64 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 65 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 68 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 69 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 70 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 71 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 72 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 73 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 74 KEY INFORMATION – PFIZER, INC.
TABLE 75 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 76 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 77 KEY INFORMATION – MEDTRONIC PLC
TABLE 78 KEY INFORMATION – KIMBERLY-CLARK CORPORATION
TABLE 79 KEY INFORMATION – STRYKER CORPORATION
TABLE 80 KEY INFORMATION – COLFAX CORPORATION
TABLE 1 LAMEA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 2 LAMEA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 3 PARTNERSHIPS, COLLABORATIONS AND AGREEMENTS– PAIN MANAGEMENT DEVICES MARKET
TABLE 4 PRODUCT LAUNCHES AND PRODUCT EXPANSIONS– PAIN MANAGEMENT DEVICES MARKET
TABLE 5 MERGERS & ACQUISITIONS – PAIN MANAGEMENT DEVICES MARKET
TABLE 6 APPROVALS – PAIN MANAGEMENT DEVICES MARKET
TABLE 7 LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 8 LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 9 LAMEA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 10 LAMEA NEUROMODULATION & NEUROSTIMULATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 11 LAMEA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 12 LAMEA ANALGESIC INFUSION PUMPS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 13 LAMEA ABLATION DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 14 LAMEA ABLATION DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 15 LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 16 LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 17 LAMEA NEUROPATHIC PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 18 LAMEA NEUROPATHIC PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 19 LAMEA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 20 LAMEA MUSCULOSKELETAL PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 21 LAMEA CANCER PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 22 LAMEA CANCER PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 23 LAMEA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 24 LAMEA FACIAL & MIGRAINE PAIN MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 25 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 26 LAMEA OTHER APPLICATIONS MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 27 LAMEA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2016 - 2019, USD MILLION
TABLE 28 LAMEA PAIN MANAGEMENT DEVICES MARKET BY COUNTRY, 2020 - 2026, USD MILLION
TABLE 29 BRAZIL PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 30 BRAZIL PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 31 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 32 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 33 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 34 BRAZIL PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 35 ARGENTINA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 36 ARGENTINA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 37 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 38 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 39 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 40 ARGENTINA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 41 UAE PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 42 UAE PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 43 UAE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 44 UAE PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 45 UAE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 46 UAE PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 47 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 48 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 49 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 50 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 51 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 52 SAUDI ARABIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 53 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 54 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 55 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 56 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 57 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 58 SOUTH AFRICA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 59 NIGERIA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 60 NIGERIA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 61 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 62 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 63 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 64 NIGERIA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 65 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, 2016 - 2019, USD MILLION
TABLE 66 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET, 2020 - 2026, USD MILLION
TABLE 67 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2016 - 2019, USD MILLION
TABLE 68 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY PRODUCT, 2020 - 2026, USD MILLION
TABLE 69 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2016 - 2019, USD MILLION
TABLE 70 REST OF LAMEA PAIN MANAGEMENT DEVICES MARKET BY APPLICATION, 2020 - 2026, USD MILLION
TABLE 71 KEY INFORMATION – ABBOTT LABORATORIES
TABLE 72 KEY INFORMATION – B. BRAUN MELSUNGEN AG
TABLE 73 KEY INFORMATION – BAXTER INTERNATIONAL, INC.
TABLE 74 KEY INFORMATION – PFIZER, INC.
TABLE 75 KEY INFORMATION – BOSTON SCIENTIFIC CORPORATION
TABLE 76 KEY INFORMATION –JOHNSON AND JOHNSON
TABLE 77 KEY INFORMATION – MEDTRONIC PLC
TABLE 78 KEY INFORMATION – KIMBERLY-CLARK CORPORATION
TABLE 79 KEY INFORMATION – STRYKER CORPORATION
TABLE 80 KEY INFORMATION – COLFAX CORPORATION
LIST OF FIGURES
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENT: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
FIG 1 METHODOLOGY FOR THE RESEARCH
FIG 2 KBV CARDINAL MATRIX
FIG 3 KEY LEADING STRATEGIES: PERCENTAGE DISTRIBUTION (2016-2020)
FIG 4 KEY STRATEGIC MOVE: (PARTNERSHIPS, COLLABORATIONS, AND AGREEMENTS: 2016, OCT – 2020, MAY) LEADING PLAYERS
FIG 5 RECENT STRATEGIES AND DEVELOPMENT: BOSTON SCIENTIFIC CORPORATION
FIG 6 RECENT STRATEGIES AND DEVELOPMENTS: MEDTRONIC PLC
